Life Sciences/Biotech

Enzo Life Sciences Debuts Sclerostin Screening System

ANN ARBOR - Enzo Life Sciences has expanded its portfolio of drug discovery screening platforms with the introduction of the new Leading Ligh Sclerostin-LRP Screening System. The Leading Light Sclerostin-LRP Screening System was developed to meet the market need for a simple, sensitive biochemical screening assay for detection of sclerostin inhibitors (antagonists of the Wnt

By |2013-10-23T00:00:00-04:00October 23rd, 2013|Archive, Life Sciences/Biotech|

Expert Says 2013 Sets Stage For Several Solid Years For Life Sciences Investments

KALAMAZOO - 2013 has been one of the strongest years in many for biotech and medical device companies to go public, a California venture capitalist said Tuesday at the MichBio Expo. Mike Carusi, General Partner of Advanced Technology Partners based in Palo Alto, California. Carusi is a General Partner and Team Leader for Lightstone Ventures,

By |2013-10-17T00:00:00-04:00October 17th, 2013|Archive, Life Sciences/Biotech|

2013 MichBio Expo In Kalamazoo Set For Oct. 15-16

KALAMAZOO ? The 2013 MichBio Expo & Conference is set for Oct. 15-16 at the Radisson Plaza Hotel in downtown Kalamazoo. The 2013 MichBio Expo will present the annual Emerging Biosciences Showcase and will feature pitches from 9 early stage, innovative bioscience start-ups across multiple industry sectors. MichBio is now accepting applications for the Emerging

By |2013-10-11T00:00:00-04:00October 11th, 2013|Archive, Life Sciences/Biotech|

Rubicon Genomics Product Helps Track Resistance Of Cancer Drugs

ANN ARBOR ? Rubicon Genomics reported that its ThruPLEXTM-FD Prep Kits contributed to the success of a breakthrough study recently published in Nature1 that showed that genomic data extracted from the plasma of cancer patients can be used to track drug resistance and potentially guide treatment. The proof-of-principle study showed that by sequencing tumor exomes

By |2013-10-01T00:00:00-04:00October 1st, 2013|Archive, Life Sciences/Biotech|

Stryker To Buy Mako For $1.65 Billion For Robotic Surgery Technology

KALAMAZOO ? Medical device giant Stryker has agreed to buy Mako Surgical Corp. for $1.65 billion to add technology for robot-assisted surgery. Investors in Mako will receive $30 a share from Stryker, the companies said Wednesday in a statement. The offer carries an 86 percent premium over Fort Lauderdale-based Mako's closing price Tuesday. Mako, founded

By |2013-09-26T00:00:00-04:00September 26th, 2013|Archive, Life Sciences/Biotech|

Israeli Medical Device Start-Ups To Make Michigan Roadshow Oct. 16

GRAND RAPIDS ? Israeli medical device start-ups will be traveling to Michigan on October 16 looking for local partners, university collaborators and private funding. The Trendlines Group in partnership with OurCrowd will be heading back to Michigan for a day-long road show that starts in Grand Rapids and finishes in Ann Arbor. ?It?s an opportunity

By |2013-09-26T00:00:00-04:00September 26th, 2013|Archive, Life Sciences/Biotech|

Michigan Prospective Health Exchange Rates Draw Praise

LANSING - The release early Wednesday of a report on expected monthly insurance rates on the federal health care exchange, which will begin accepting enrollment on Tuesday, showed that monthly rates in Michigan will be slightly less than the national average, and the news drew praise from supporters of the controversial Patient Protection and Affordable

By |2013-09-26T00:00:00-04:00September 26th, 2013|Archive, Life Sciences/Biotech|

Metabolomics Center Gets $9 Million NIH Grant

ANN ARBOR ? The Southeast Center for Integrated Metabolomics has been awarded a five-year, $9 million grant from the National Institutes of Health. IROA Technologies, formerly NextxGen Metabolomics, is a founding member along with the University of Florida. With the grant funding, the SECIM is developing an integrated metabolomics service to provide highquality data, user-friendly

By |2013-09-26T00:00:00-04:00September 26th, 2013|Archive, Life Sciences/Biotech|

Schuette, LARA Team Up To Regulate Compounding Pharmacies

LANSING - Attorney General Bill Schuette on Thursday announced another effort to try to better enforce regulations against compounding facilities like the New England Compounding Center largely held responsible for the national meningitis outbreaks last fall due to use of tainted pain killer drugs. In addition to a grand jury and other investigations ongoing related

By |2013-09-19T00:00:00-04:00September 19th, 2013|Archive, Life Sciences/Biotech|

Southwest Michigan Innovation Center Uses Virtual Visit To Showcase Incubator

KALAMAZOO ? Rob DeWitt, president and CEO of the Southwest Michigan Innovation Center, said he?s using the Internet to reach out to the life sciences industry to present a virtual visit to SMIC on its 10th anniversary. On Oct. 9, SMIC will host ?Leading Life Sciences: A Virtual Visit,? an online exploration of the incubator,

By |2013-09-19T00:00:00-04:00September 19th, 2013|Archive, Life Sciences/Biotech|